If you’ve ever been to the Netherlands, that title is a bit confusing; but the reality of the Netherlands is that it doesn’t operate how most think. In a recent turn of events; the Netherlands announced it would open legal and limited cannabis sales, to investigate a legal market.

Netherlands to open legal cannabis sales

Before we get into why this is a weird title, let’s first dive right into the current news story. The story started back in February of this year, when Netherlands Health Minister Ernst Kuipers announced what sounds like a cannabis pilot program; which would provide limited legal cannabis sales to specific areas of the country. He announced that Tilburg and Breda would be the first places to enjoy this new market; but that a total of about 10 municipalities could be involved.

For those unfamiliar with what a cannabis pilot program is, its essentially an experiment into how to run a cannabis sales market. We see the same thing in Switzerland, which approved a program for Zurich; and it’s expected that Germany will begin a similar setup within the next year. Germany had originally planned for a full sales market, but did a quick and extreme about-face when it became clear the EU would not allow it.

This idea of needing to accommodate the EU is important here, because it applies to the Netherlands as well. If Germany is not legally capable of pushing a policy the EU doesn’t agree with, the Netherlands can’t either. Meaning Germany now shows us the utmost of what can be expected for an EU country on the legal weed front. In terms of Switzerland, though the country chose to wade in with limited legal sales as a part of a pilot program; it has no need to care about EU policy, as its not a part of the EU.

The Netherlands has been planning this for a little while now, but met a few delays along the way; mainly in having enough licensed cultivators in the necessary regions of study. For example, the Tilburg and Breda locations only have a couple licensed cultivators to provide coffee shops with product.

Prior to the most recent announcement, the country didn’t want to start a pilot program without at least three cultivators ready to go. The Netherlands changed stance, and is now ready to allow the Tilburg and Breda locations to open; with two more cultivators expected to join in, in early 2024. The eight additional pilot programs will not open unless these two locations work out. Feelings are generally optimistic.

When it was first announced in February, Breda’s Mayor, Dr. Paul Depla stated, “With this start-up phase in Brabant we can gain first experiences, detect teething problems and gather the knowledge to perfect the experiment. In this way, we can make a flying start with the large-scale experiment.”

Apart from the designated areas like Tilburg and Breda, the country will also open at least one part of Amsterdam to legal sales as well. If you know anything about the Netherlands and weed, this move is necessary, but we’ll get to that in a minute. Overall, should authorities decide they are unhappy with this new program, it can be shut down.

Why a pilot program for legal cannabis sales is funny

Let’s be honest for a second, the Netherlands has enjoyed cannabis sales to the public for decades of time. In this changing world of cannabis reform, the Netherlands is no longer the sole focal point of the weed world, but it was for a really long time. Long enough that this policy is a bit laughable. Of all countries, there is none other that has as much accumulated knowledge of how to run a cannabis sales market. And yet here it is, acting like these first legal sales, are some kind of entrance into a new world.

To be clear, cannabis is not legal in the Netherlands; and it hasn’t been in the entire time the country has built up its industry. Cannabis has been illegal in the country since 1928’s passage of the Opium Act; although since 1972, a Policy of Tolerance has allowed the use of cannabis in coffee shops, without punishment to either vendors or buyers. Law enforcement can choose whether to make a big deal over a specific occurrence; but usually its all ignored unless children are involved.

Cannabis is decriminalized up to five grams for personal use, which includes the ability to cultivate up to five plants. Greater amounts than this can incur a fine up to €75, or prison time; depending on amount and purpose. When it comes to cultivation, law enforcement generally looks for those illegally growing for commercial purposes.

In terms of basic cannabis laws, the Netherlands isn’t that far off from other European countries; and a look at policy on the surface doesn’t indicate that this country functions differently than others. However, the Policy of Tolerance has spawned a huge market of coffee shops which provide cannabis sales, particularly in the capital of Amsterdam.

Netherlands Policy of Tolerance vs pilot program

A cannabis pilot program is meant to gain information on how to run a legal sales market. Logically, though, these markets are already open in different countries, which makes the idea of it as an experiment, a little late in the game. Perhaps simply looking at the positives and detractions of other markets is now more functionally useful. Or, in the case of the Netherlands, it really only has to gather data on its already existent coffee shop market.

While the pilot program step is a little unnecessary in places like Switzerland and Germany, its gravely unnecessary in the Netherlands. Like every other place, the Netherlands wants a taxable market; as the government currently has no control of the coffee shop system, or the illegal cultivation that supplies the shops. But in terms of how to do it, literally no country has more answers than the Netherlands. Even if you want to argue that it doesn’t have experience in legal production; it actually does! The Netherlands legalized medical cannabis, and a medical sales market, in 2003.

The current coffee shops have been running since the mid-1970’s. We’re literally in the 5^th decade of information collection. And it’s not like the shops run completely lawlessly. IDs are checked. Maximum sales amounts are instituted. Alcohol and hard drugs are separated. Weapons are prohibited. Taxes are collected. This is a market operating in daylight, and it’s been going on for over half a century. There are sales statistics involved. The Netherlands ‘trying out cannabis sales’ is like Mexico ‘trying out taco sales.’

Regardless of the lack of logic, this is what the Netherlands is now planning. And realistically, its not all about logic; its also about finding a way to make a taxable market, within EU guidelines. Its quite possible that without the EU overseeing everything; that the Netherlands might have taken this step a long time ago. There is an incredibly silly aspect to it, sure, but there is also a reality that makes this silly concept, the only thing the Netherlands can do.

What to expect

In past years, the government spoke more about trying to end the weed tourism market in the country, but always to no avail. This new policy is more in line with the understanding of the inability to prohibit cannabis use; for both residents and tourists. In light of understanding a lack of control over the markets, many governments have changed tack and legalized the plant, in order to make it a taxable market they can benefit from.

But is there any way the government is going to change such a long-standing system in the Netherlands? Will it ruin what is already there, or make it less preferable for consumers? There are plenty of options in the world of weed tourism these days. Can the Netherlands market withstand tampering by the government?

I don’t know. It’s hard to imagine anything fundamentally changing the system now; but this doesn’t mean it can’t be done. If Amsterdam still stood as the main weed tourism location, government involvement might be less meaningful. But, governments tend to institute high taxes and regulatory fees, which raise prices. With more options available in the world, the Netherlands government might have stumbled on the one way to get rid of its gray cannabis sales market: make it legal!

Conclusion

Amsterdam reined supreme as the world’s weed capital for a long time; but things are changing. The new question now is how well the Netherlands can tolerate an actually legal sales market; complete with all standard government interference.

Welcome weed supporters! We’re glad you made it to Cannadelics.com; where we work hard to bring you the most interesting news and commentary in the growing worlds of cannabis and hallucinogens. Come by frequently to stay in-the-loop; and get subscribed to the Cannadelics Weekly Newsletter; to ensure you’re never late to get the news.

Like this:

Like Loading…

Related

If you had to guess, how many people in the United States do you think live with fibromyalgia? According to the Centers for Disease Control (CDC), roughly four million American adults (2% of the country’s population) struggle with this chronic medical condition. But what is the research about fibromyalgia and cannabis? Overall, there is some evidence supporting short-term pain reduction in people with fibromyalgia treated with cannabinoid therapeutics. Although current evidence is limited, medical cannabis appears to be a safe alternative for treatment.

Fibromyalgia consists of widespread, severe, and often overwhelming musculoskeletal pain. Regardless of the traditional fibromyalgia treatment methods that currently exist, to help combat the pain and other uncomfortable symptoms associated with this condition, cannabis as an alternative medicine is gaining traction and usage.

Fibromyalgia: A Day In the Life

Fibromyalgia is one of the most common chronic pain syndromes, and it consists of intense musculoskeletal pain and other accompanying symptoms. Unfortunately, fibromyalgia does more than just cause pain. This chronic condition can result in sleep issues or sleep disorders, fatigue and lethargy, and even emotional or mental distress. It doesn’t stop here though. A few other common fibromyalgia symptoms include headaches and migraines, depression and anxiety, memory and concentration issues, and overall body stiffness.

Fibromyalgia takes it a step further though by often wreaking havoc on an individual’s quality of life and overall well-being. However, there’s a light at the end of the tunnel for fibromyalgia patients, and this is the availability and usage of cannabinoids, especially following the  noteworthy discovery of cannabis’s analgesic properties.

Even though pharmaceutical drugs and over-the-counter (OTC) pain-relievers are typically used to help manage fibromyalgia, due to emerging medical evidence, cannabinoids like CBD and THC are being considered more now than ever before.

The Evolving Relationship Between Fibromyalgia and Cannabis

Thus far, it has been made clear that cannabinoids can act as analgesics, and recent research findings support cannabinoids as a fibromyalgia pain-reliever. For example, one 2020 randomized controlled trial was conducted to understand how THC-rich whole cannabis plant oil can help fibromyalgia patients in regards to treating their symptoms and improving their quality of life.

RELATED: Study: Medical Marijuana Improves Quality Of Life In Fibromyalgia Patients

It was concluded that phytocannabinoids can serve as an affordable yet well-tolerated therapy for fibromyalgia symptom relief and quality of life improvements. For those who don’t already know, cannabis flower contains more than 100 phytocannabinoids, and two of the most well-known and sought after ones are referred to as THC (tetrahydrocannabinol) and CBD (cannabidiol).

The trial’s researchers went further to suggest that this cannabinoid therapy method could become an herbal/holistic choice of medicine for the treatment of fibromyalgia in Brazil’s public healthcare system.

The Significance of the Endocannabinoid System

Regardless of the latest findings, longer and larger studies should be conducted to understand more about phytocannabinoids and fibromyalgia. Another area that should be further studied and analyzed is the body’s endocannabinoid system (ECS) and endocannabinoid system deregulations and deficiencies. 

RELATED: Acute And Chronic Pain Affects Millions — How Can Cannabis Help?

Researchers from the same 2020 controlled trial stated the following about the ECS and medical conditions such as fibromyalgia: “Some studies suggest that pathological conditions in pain modulation such as fibromyalgia, migraine, and irritable bowel syndrome, among others, may be, at least in part, related to the deregulation of the endocannabinoid system.”

The last 2.5 years have been tough for the recreational marijuana industry.  Flower prices have plummeted, New York had a fiasco of a recreational rollout, and some major companies have been on the edge of collapse. But things are changing. The slow moving Biden administration has finally agreed to talk about rescheduling and SAFE Banking again goes before a Congress in turmoil. Is the cannabis industry growing up and starting to act and perform like other mainstream industries?

Despite the trouble, consumer use it up with the long term base of customers growing. While 90% believe it should be legal in some form, about 46% of adults have used marijuana at least once.  The under 40 set sees it almost like beer, sodas and fast food, just a life option.  One key positive for this information is they are more likely to try new products unlike the 65+ who are much less likely to try new things.

RELATED: California or New York, Which Has The Biggest Marijuana Mess

Signs of the industry emerging from its growing pains are clear.  The industry is adjusting reality.  As a $22+ billion industry in 2022, it wants to act like a $250+ billion industry. But market forces are right-sizing in a variety of ways.  There were over 750 conferences/trade shows/ investor conferences in 2018, now there are roughly 200.  Indoor grow companies, the most expensive way to produce, are having to adjust pricing.  Some are threatened with closing because of their assumption of always high premiums.  Commodity fluctuating pricing used in everything from oil to butter has come to weed.  But consumers are still buying in droves, even Montana boosted high sales.

“In most industries, at first everyone wants in and thinks they can make a quick fortune immediately. When that happens people are misguided by false information and the wrong people from other shady pasts thinking they know it all. The cannabis industry is no different and it will act like other successful ones. We needed this readjustment, most of the bad players are out, the misinformed are on the sidelines and the ones who put the time and proper energy into the space are still around and will thrive.” says Andrew Laub, managing partner of Keneh Ventures.

Big names have also struggled recently.  Medmen, King’s Garden, The Parent Company, and others all closed or are a faction of where they were. The early days with promises of easy money, private jets, crazy parties, and hot eye candy swarming around have passed and now it is spread sheets, hard work and focus. Canopy Grow has moved operations from Canada to the US and is applying all the learnings from a highly successful alcohol company to a major player in marijuana.

The industry has also slowly moved to listening to consumers.  Marley brands have fallen away to Wana Brand’s products which appeal to a younger, diverse audience. As the future looks to legalization, product companies are increasingly looking at what will do well on the shelves of Walmart and Target and not something to snicker about with bro friends.

RELATED: 

“The industry is evolving at a quicker pace today due to the assumed changes to cannabis scheduling with the Controlled Substance Act and possible SAFE Banking Act passing in Congress in some form of tandem news. This is causing mainstream investing to get excited again about cannabis, but mainstream does their due diligence and only wants to invest their money in competent and honest people.” shares Curt Dalton, founder of Cannabis.net.

While the industry still has work, large investors see the future where there are fewer products with large distribution, indoor grow and cheap base prices, and a giant consumer base who will look to familiar places to purchase products.